Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Herting
Egbert Herting, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20080305180 | Method of administration of a pulmonary surfactant - The present invention concerns a method for treating a respiratory distress in a infant in need of such treatment, the method comprising intratracheal administration of a pulmonary surfactant by a thin tube. | 12-11-2008 |
Frank Herting, Penzberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090246197 | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) - The present invention is directed to a pharmaceutical composition comprising: (A) a type II anti-CD20 antibody with increased antibody dependent cellular cytotoxicity (ADCC); and (B) a chemotherapeutic agent selected from the group consisting of: cyclophosphamide, vincristine and doxorubicine. | 10-01-2009 |
| 20100310581 | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) - The present invention is directed to a pharmaceutical composition comprising: (A) a type II anti-CD20 antibody with increased antibody dependent cellular cytotoxicity (ADCC); and (B) a chemotherapeutic agent selected from the group consisting of: cyclophosphamide, vincristine and doxorubicine. | 12-09-2010 |
| 20110165151 | COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE - The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with bendamustine for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and bendamustine. | 07-07-2011 |
| 20110165152 | COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE - The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody with fludarabine and/or mitoxantrone. | 07-07-2011 |
Frank Herting, Sindelsdorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20100267632 | Treatment of neurodegenerative disorders - A method of treating neurodegenerative disorders of the brain and spinal cord is disclosed. The therapeutic agent is a polyethylene glycol linked protein. | 10-21-2010 |
Rainer Herting, Hellenhahn DE
| Patent application number | Description | Published |
|---|---|---|
| 20090133559 | Power tool - A power tool comprising a housing displaceably mounted to a foot plate, a blade, a motor, an electric switch and an interlock for controlling movement of the housing with respect to the foot plate. The interlock has a control button mounted to one of the housing or foot plate which cooperates with a channel fixed in relation to the other of the housing or foot plate. The control button can select between a plunge cut mode wherein the blade can protrude below the foot plate, or a blade change mode wherein the blade is prepared for a blade change operation. The channel comprises a major leg in communication with a minor leg. Cooperation between the control button and the major leg selects the plunge cut mode. Cooperation between the control button and the minor leg selects the blade change mode. The interlock may also comprise a housing lock and a spindle lock. | 05-28-2009 |